Inovio Pharmaceuticals Company
Inovio Pharmaceuticals engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP.
Investors
.png)
Funding Status:
N/A
Headquarters:
United States
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Technology:
COVID
Employee Number:
N/A
Number Of Exists:
N/A
Industry:
Genomic and Epigenominc Instabillity